First Time Loading...

Omeros Corp
NASDAQ:OMER

Watchlist Manager
Omeros Corp Logo
Omeros Corp
NASDAQ:OMER
Watchlist
Price: 3.73 USD 0.27% Market Closed
Updated: May 5, 2024

Omeros Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Omeros Corp
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Omeros Corp
NASDAQ:OMER
Operating Income
-$164.5m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
Johnson & Johnson
NYSE:JNJ
Operating Income
$24.3B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$10.5B
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Operating Income
$10.6B
CAGR 3-Years
-6%
CAGR 5-Years
11%
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Operating Income
$6.6B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Operating Income
$11.3B
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
9%

See Also

What is Omeros Corp's Operating Income?
Operating Income
-164.5m USD

Based on the financial report for Dec 31, 2023, Omeros Corp's Operating Income amounts to -164.5m USD.

What is Omeros Corp's Operating Income growth rate?
Operating Income CAGR 10Y
-13%

Over the last year, the Operating Income growth was -1%. The average annual Operating Income growth rates for Omeros Corp have been -14% over the past three years , -8% over the past five years , and -13% over the past ten years .